title: Hypertrophic osteoarthropathy associated with docetaxel treatment.
authors.forename: F
authors.initials: F
authors.lastname: Tas
authors.forename: A
authors.initials: A
authors.lastname: Aydiner
authors.forename: N
authors.initials: N
authors.lastname: Tenekeci
authors.forename: A
authors.initials: A
authors.lastname: Karadeniz
authors.forename: B
authors.initials: B
authors.lastname: Sakar
authors.forename: E
authors.initials: E
authors.lastname: Topuz
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy / Q000601:surgery; D003937:Diagnosis, Differential; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008408:Mastectomy; D008875:Middle Aged; D010005:Osteoarthropathy, Secondary Hypertrophic / Q000175:diagnosis* / Q000209:etiology; D017239:Paclitaxel / Q000009:adverse effects* / Q000031:analogs & derivatives; D043823:Taxoids
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel